Basic Information
Basic information for MIR646HG-238-31aa-1
Peptide Name MIR646HG-238-31aa-1
Genome Position chr20:60180846-60180913,60527387-60527411[+]
Species Human
Peptide Sequence MSLPWSERACEGGAGVHQGSSYRDDRRDIQE
Peptide Length 31
Unique No (MIR646HG-261-31aa,MIR646HG-267-31aa)
Grand Average of Hydropathicity -1.2032
Relative Molecular Mass 4034.17
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000659856;MIR646HG-238
Transcript Length 3592
Coding Ability 0.3978
DNA Sequence Corresponding to Peptide ATGAGCCTCCCGTGGTCGGAACGGGCTTGTGAAGGCGGTGCTGGGGTGCACCAGGGCAGCAGCTACAGAGATGACAGAAGAGACATCCAGGAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :